Search Results - "Yoshimitsu, M"

Comparative whole‐exome sequencing of an ultra‐late recurrent malignant melanoma by Nakamura, M., Obayashi, M., Yoshimitsu, M., Kato, H., Morita, A.

Get full text

PD-1 PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia lymphoma patients by Kozako, T, Yoshimitsu, M, Fujiwara, H, Masamoto, I, Horai, S, White, Y, Akimoto, M, Suzuki, S, Matsushita, K, Uozumi, K, Tei, C, Arima, N

“…Adult T-cell leukemia/lymphoma (ATLL) develops after infection with human T-cell leukemia virus-1 (HTLV-1) after a long latency period. The negative regulatory…”
Get full text

Overexpression of NAMPT in adult T-cell leukemia/lymphoma patients and anti-tumor activity of a NAMPT inhibitor in vivo by Kozako, T., Ohsugi, T., Yoshimitsu, M., Uchida, Y.-I., Ishitsuka, K., Naho, K., Aikawa, A., Honda, S.-I.

Get full text

A PHASE 2 TRIAL OF CHOP WITH ANTI‐CCR4 ANTIBODY MOGAMULIZUMAB FOR ELDERLY PATIENTS WITH CCR4‐POSITIVE ADULT T‐CELL LEUKEMIA/LYMPHOMA by Utsunomiya, A., Kusumoto, S., Choi, I., Yoshimitsu, M., Shimokawa, M., Suehiro, Y., Hidaka, T., Nosaka, K., Sasaki, H., Rai, S., Tamura, S., Owatari, S., Koh, K., Hidaka, M., Kato, T., Jo, T., Moriuchi, Y., Ogata, M., Ohtsuka, E., Suzushima, H., Ito, S., Yoshida, S., Ito, A., Nakamura, D., Tokunaga, M., Sekine, M., Sakamoto, Y., Inagaki, H., Ishida, T., Ishitsuka, K.

Get full text

P-053Updated analysis of induction & maintenance adjuvant chemotherapy with 3-month oxaliplatin-based regimen followed by 3 months capecitabine in patients with stage III and high-risk stage II colorectal cancer :(JSWOG C2) by Tanioka, H, Yamashita, K, Tsuruta, A, Tsuji, A, Nagasaka, T, Okumura, H, Oka, Y, Inukai, M, Yamakawa, T, Yamatsuji, T, Yoshimitsu, M, Toyota, K, Yamano, T, Okajima, M

Get full text

Recombinant human soluble thrombomodulin for the treatment of hepatic sinusoidal obstructive syndrome post allogeneic hematopoietic SCT by Nakamura, D, Yoshimitsu, M, Kawada, H, Inoue, H, Kuroki, T, Kaieda, T, Fujino, S, Hamada, H, Suzuki, S, Matsushita, K, Uozumi, K, Arima, N

Get full text

Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem progenitor cells by YOSHIMITSU, M, HIGUCHI, K, RAMSUBIR, S, NONAKA, T, RASAIAH, V. I, SIATSKAS, C, LIANG, S.-B, MURRAY, G. J, BRADY, R. O, MEDIN, J. A

“…A deficiency in alpha-galactosidase A (alpha-gal A) activity causes Fabry disease. Virus-based delivery of genes can correct cells and establish a sustained…”
Get full text

Successful allo-HSCT with a minimal myeloablative conditioning regimen in an adult patient with Fanconi's anemia by Maekawa, K, Yoshimitsu, M, Fujiwara, H, Matsushita, K, Kawada, H, Hamada, H, Suzuki, S, Uozumi, K, Ohtsuka, M, Hanada, S, Yabe, M, Yabe, H, Arima, N

Get full text

QS284. Risk Factors for Anastomotic Leakage Following Laparoscopic Surgery of Middle and Low Rectal Cancers: Multicenter Study by Japan Society of Laparoscopic Colorectal Surgery by Hinoi, T, Okajima, M, Ikeda, S, Yoshimitsu, M, Konishi, F, Watanabe, M

Get full text

1204 Immunogenic cell death by inhibition of glucose-6-phosphate dehydrogenase enhances the efficacy of immunotherapy in malignant melanoma by Nakamura, M., Yoshimitsu, M., Magara, T., Kano, S., Kato, H., Morita, A.

Get full text

1250 Induction of tertiary lymphoid structures in a mouse melanoma model under a combination of CXCL13 and anti-PD-1 antibody by Yoshimitsu, M., Nakamura, M., Kano, S., Magara, T., Kato, H., Morita, A.

Get full text

278 Tumor immune microenvironment of cutaneous angiosarcoma with cancer-testis antigens and tertiary lymphoid structures by Magara, T., Nakamura, M., Yoshimitsu, M., Kano, S., Kato, H., Morita, A.

Get full text

458 Tertiary lymphoid structures improve survival in virus-negative Merkel cell carcinoma by Nakamura, M., Magara, T., Yoshimitsu, M., Kano, S., Matsubara, A., Kato, H., Morita, A.

Get full text

452 Cancer-testis antigens correlate with the prognosis and formation of tertiary lymphoid structures in cutaneous angiosarcoma by Magara, T., Nakamura, M., Nojiri, Y., Yoshimitsu, M., Kano, S., Matsubara, A., Kato, H., Morita, A.

Get full text

033 Excision of halo nevus without PD-L1 expression may cure vitiligo by Kano, S., Nakamura, M., Yoshimitsu, M., Magara, T., Nojiri, Y., Matsubara, A., Kato, H., Morita, A.

Get full text

275 Tertiary lymphoid structures correlate with better prognosis in cutaneous angiosarcoma by Magara, T., Nakamura, M., Nojiri, Y., Yoshimitsu, M., Kano, S., Matsubara, A., Kato, H., Morita, A.

Get full text

Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma by Kataoka, Keisuke, Iwanaga, Masako, Yasunaga, Jun-ichirou, Nagata, Yasunobu, Kitanaka, Akira, Kameda, Takuro, Yoshimitsu, Makoto, Shiraishi, Yuichi, Sato-Otsubo, Aiko, Sanada, Masashi, Chiba, Kenichi, Tanaka, Hiroko, Ochi, Yotaro, Aoki, Kosuke, Suzuki, Hiromichi, Shiozawa, Yusuke, Yoshizato, Tetsuichi, Sato, Yusuke, Yoshida, Kenichi, Nosaka, Kisato, Hishizawa, Masakatsu, Itonaga, Hidehiro, Imaizumi, Yoshitaka, Munakata, Wataru, Shide, Kotaro, Kubuki, Yoko, Hidaka, Tomonori, Nakamaki, Tsuyoshi, Ishiyama, Ken, Miyawaki, Shuichi, Ishii, Ryohei, Nureki, Osamu, Tobinai, Kensei, Miyazaki, Yasushi, Takaori-Kondo, Akifumi, Shibata, Tatsuhiro, Miyano, Satoru, Ishitsuka, Kenji, Utsunomiya, Atae, Shimoda, Kazuya, Matsuoka, Masao, Watanabe, Toshiki, Ogawa, Seishi

“…Adult T-cell leukemia/lymphoma (ATL) is a heterogeneous group of peripheral T-cell malignancies characterized by human T-cell leukemia virus type-1 infection,…”
Get full text

262 Glucose-6-Phosphate Dehydrogenase is a Promising Biomarker for Prognosis and Immune Activity Prediction in Merkel Cell Carcinoma by Nakamura, M., Nagase, K., Yoshimitsu, M., Magara, T., Nojiri, Y., Kato, H., Kobayashi, T., Teramoto, Y., Yasuda, M., Wada, H., Ozawa, T., Ogata, D., Morita, A.

Get full text

P-17 Prevalence of HTLV-I carriers among patients with MDS RAEB and AML by Matsushita, K., Inoue, H., Ozaki, A., Fujiwara, H., Kawada, H., Yoshimitsu, M., Arimura, K., Kukita, T., Matsumoto, T., Arima, N.

Get full text

045 Glucose-6-phosphate dehydrogenase is a promising predictor of immunotherapy response for Merkel cell carcinoma by Nakamura, M., Nagase, K., Yoshimitsu, M., Magara, T., Nojiri, Y., Kato, H., Kobayashi, T., Teramoto, Y., Yasuda, M., Wada, H., Ozawa, T., Umemori, Y., Ogata, D., Morita, A.

Get full text